Financial News · Live Terminal

Page 278 of 298

BTIG Initiates Henry Schein at Neutral

Henry Schein (HSIC) has an average rating of overweight and mean price target of $90, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$HSIC

Research69d ago

YES Research Downgrades ICICI Lombard General Insurance to Add from Buy; Price Target is INR2,200

ICICI Lombard General Insurance (BOM:540716, NSE:ICICIGI) has an average rating of overweight and mean price target of 2,141.07 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:540716NSE:ICICIGI

Research69d ago

Huatai Research Starts First Pacific Company at Buy with HK$6.74 Price Target

HKG:0142

Research69d ago

Mizuho Initiates Equifax at Outperform With $222 Price Target

Equifax (EFX) has an average rating of overweight and mean price target of $228.41, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$EFX

Research69d ago

Mizuho Initiates Fair Isaac at Outperform With $1,416 Price Target

Fair Isaac (FICO) has an average rating of overweight and mean price target of $1,667.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$FICO

Research69d ago

CICC Initiates Pfizer at Outperform With $33 Price Target

Pfizer (PFE) has an average rating of hold and mean price target of $28.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$PFE

Research69d ago

Mizuho Downgrades PayPal Holdings to Neutral From Outperform, Adjusts PT to $50 From $60

PayPal Holdings (PYPL) has an average rating of hold and mean price target of $49.42, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$PYPL

Research69d ago

Krungsri Securities Upgrades Siam Cement to Buy from Neutral; Price Target is THB245

Siam Cement (BKK:SCC) has an average rating of hold and mean price target of 202.47 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BKK:SCC

Research69d ago

Krungsri Securities Downgrades Advanced Info Service to Neutral from Buy; Price Target is THB390

Advanced Info Service (BKK:ADVANC) has an average rating of overweight and mean price target of 391.57 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BKK:ADVANC

Research69d ago

DBS Bank Upgrades WHA Premium Growth Freehold and Leasehold REIT to Buy from Hold; Price Target is THB11.50

BKK:WHART

Research69d ago

Research Alert: Aegon's Sale Of U.k. Division To Standard Life: A Positive Lift To Book Value

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Aegon's sale of its U.K. operations to Standard Life for GBP2.0 billion (GBP750 million cash + 15.3% equity stake) is positive. The deal values the business at 14.2x 2025 operating earnings (vs. the 12x group multiple) and 1.9x equity (group: 1.2x). In 2025, Aegon UK contributed EUR219 million in operating result (12% of group), GBP1.4 billion in CSM (19%), and GBP246 billion in AUM (32%). Aegon's U.K. asset management remains as strategic partner to the combined entity, creating Britain's largest retirement provider with 16 million customers and GBP480 billion in assets. The transaction could boost Aegon's book value by ~15% while reducing 2027 earnings by 5%, although the cash proceeds enable buybacks to offset the EPS dilution. Aegon becomes Standard Life's largest shareholder with board representation. This completes Aegon's U.K. strategic review, accelerating its U.S. transformation toward 2028 redomiciliation as Transamerica. The sale is expected to close in end-2026 subject to regulatory approvals.

$AEG

Research69d ago

MIDF Amanah Downgrades UOA Development to Neutral from Buy; Price Target is MYR1.86

KLSE:UOADEV

Research69d ago

Bualuang Securities Downgrades Siam Cement to Sell from Hold; Price Target is THB260

Delta Electronics Thailand (BKK:DELTA) has an average rating of overweight and mean price target of 243.72 baht, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BKK:DELTA

Research69d ago

JM Financial Starts VA Tech Wabag at Buy with INR1,755 Price Target

VA Tech Wabag (NSE:WABAG, BOM:533269) has an average rating of buy and mean price target of 1,866.57 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:533269NSE:WABAG

Research69d ago

Avendus Spark Starts Amagi Media Labs at Buy with INR430 Price Target

BOM:544679NSE:AMAGI

Research69d ago

Macquarie Upgrades The Indian Hotels to Outperform from Neutral; Price Target is INR770

The Indian Hotels (NSE:INDHOTEL, BOM:500850) has an average rating of buy and mean price target of 801.21 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

BOM:500850NSE:INDHOTEL

Research69d ago

Nomura Starts Sinfonia Technology at Buy with 18,000 Yen Price Target

TYO:6507

Research69d ago

Nomura Starts Oki Electric Industry at Buy with 4,200 Yen Price Target

TYO:6703

Research69d ago

Research Alert: Tsmc: Q1 2026 Results In Line, Supported By Ai Demand And Margin Upside

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:TSMC's Q1 2026 results were in line with expectations, with net profit rising 13% Q/Q and 58% Y/Y to TWD572B, representing 23%-24% of full-year estimates, while revenue increased 8% Q/Q and 35% Y/Y to TWD1,134B. Margins exceeded management guidance, with gross margin at 66% (vs. 65% guidance) and operating margin at 58% (vs. 56% guidance), supported by higher utilization, better cost control, and favorable forex rates. Strong AI-led demand drove advanced nodes, which accounted for 74% of wafer revenue, while the HPC segment grew 20% Q/Q to 61% of total revenue, offsetting weaker smartphone and automotive demand. Management's outlook points to continued HPC strength and ongoing 3nm ramp supporting further revenue growth. We view the results as consistent with a strong AI-led cycle, with growth likely to continue into Q2 2026 but with a more balanced trajectory as new capacity ramps. Overall, earnings visibility remains strong, with AI demand continuing to anchor performance.

$TSM

Research69d ago

Research Alert: CFRA Keeps Hold Opinion On Adss Of Ubs Group Ag

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to USD47 from USD41, reflecting an expansion in our applied P/E multiple to 14.8x from 12.6x on unchanged 2026 EPS estimates. This multiple expansion is justified by (1) the compression in the equity risk premium since our March 20 report, due to easing geopolitical tensions and improving market sentiment, (2) U.S. investment banking peers' strong Q1 2026 results validating the return of the M&A and wealth management cycles, and (3) incremental positive signals regarding Swiss regulatory capital framework compromises. The ~15% share price appreciation since March 20 aligns with similar moves across the European banking peer group, confirming this as largely a sector-wide re-rating. While we maintain our Hold rating given limited near-term upside from current levels, the regulatory capital framework decision expected this month (April 22-23) represents a potential catalyst that could swing our view. UBS will release its Q1 2026 results on April 29.

$UBS

Showing 5541-5560 of 5954